News|Articles|August 1, 2023
Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia
Author(s)Mikart
Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
AAPS PharmSci 360 2025: Trends in Bioanalysis
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
